QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 oncology-institute-affirms-fy2025-sales-guidance-of-460000m-480000m-vs-465100m-est

Oncology Institute (NASDAQ:TOI) affirms FY2025 sales outlook from $460.000 million-$480.000 million to $460.000 million-$480.00...

 the-oncology-institute-q2-eps-015-misses-013-estimate-sales-119802m-beat-114600m-estimate

The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate ...

 b-riley-securities-initiates-coverage-on-oncology-institute-with-buy-rating-announces-price-target-of-6

B. Riley Securities analyst Yuan Zhi initiates coverage on Oncology Institute (NASDAQ:TOI) with a Buy rating and announces P...

 the-oncology-institute-named-exclusive-oncology-provider-for-80k-silversummit-medicaid-patients-in-nevada-starting-july-1-2025

The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI"), one of the largest value-based oncology groups in the United States,...

 the-oncology-institute-files-for-stock-shelf-of-up-to-50m

-SEC Filing

 oncology-institute-affirms-fy2025-sales-guidance-of-46000m-48000m-vs-48280m-est

Oncology Institute (NASDAQ:TOI) affirms FY2025 sales outlook from $460.00 million-$480.00 million to $460.00 million-$480.00 mi...

 the-oncology-institute-q1-gaap-eps-021-up-from-022-yoy-sales-10441m-up-from-9467m-yoy

The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.21) per share. This is a 4.55 percent increase over losses...

 the-oncology-institute-files-prospectus-for-the-resale-of-up-to-2792m-shares-of-common-stock-by-selling-securityholders

The Oncology Institute, Inc.27,924,611 SharesCommon StockOffered by the Selling Securityholders This prospectus relates to the ...

 the-oncology-institute-announces-enterprise-wide-expansion-of-strategic-partnership-with-helios-clinical-research

CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Compa...

 the-oncology-institute-expects-fy2025-revenue-of-460m-480m-vs-consensus-of-48280m

 2025 Guidance Revenue$460 to $480 million Gross Profit$73 to $82 million Adjusted EBITDA$(8) to $(17) million Free Cash Flow$(...

 the-oncology-institute-entered-into-a-securities-purchase-agreement-with-accredited-investors-for-a-private-placement-in-gross-proceeds-of-approximately-165m

Pursuant to the terms of the Securities Purchase Agreement, the Company will issue to purchasers in the Private Placement units...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION